Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026)
Corcept Therapeutics (CORT) reported Exchange Rate Effect of -$287000.0 for Q1 2026, down 180.17% on a YoY basis from $358000.0 in Q1 2025, and down 796.88% sequentially from -$32000.0 in Q4 2025.
Corcept Therapeutics (CORT) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 3 years of Exchange Rate Effect data on file, last reported at -$287000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 180.17% year-over-year to -$287000.0; the trailing twelve-month figure through Mar 2026 stood at $797000.0 (changed N/A YoY), and the FY2025 full-year result was $1.4 million, up 732.46% from the prior year.
- Exchange Rate Effect fell to -$287000.0 in Q1 2026, from -$32000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.4 million in Q2 2025 to a low of -$758000.0 in Q4 2024.
- A 3-year average of $133285.7 and a median of -$32000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 95.78% in 2025 and slumped 180.17% in 2026, its largest moves.
- Tracing CORT's Exchange Rate Effect over 3 years: stood at -$758000.0 in 2024, then jumped by 95.78% to -$32000.0 in 2025, then plunged by 796.88% to -$287000.0 in 2026.
- Business Quant data shows CORT's Exchange Rate Effect at -$287000.0 in Q1 2026, -$32000.0 in Q4 2025, and -$320000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | -287,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -287,000.00 |
| Mar 31, 2026 | -287,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Jun 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 358,000.00 |
| Mar 31, 2025 | 358,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Sep 30, 2024 | 536,000.00 |
| Sep 30, 2024 | 536,000.00 |